Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Neuronal (Paraneoplastic) Autoantibodies Profile, CSF is 14 days.

What are the prerequisites for the test Neuronal (Paraneoplastic) Autoantibodies Profile, CSF

  • Patient must have symptoms suggestive of a paraneoplastic neurological syndrome including ataxia, opsoclonus, limbic encephalitis, or stiff person syndrome.
  • Patient must have a known or suspected underlying neoplasm, especially small cell lung carcinoma, thymoma, or breast carcinoma.
  • CSF analysis must show evidence of inflammation, such as elevated white blood cell count or protein levels.
  • Patient must have had negative results for other causes of neurological symptoms, such as infection or metabolic disorders.

What are the measure values for the test Neuronal (Paraneoplastic) Autoantibodies Profile, CSF

Autoantibody Reference Range
Anti-Hu Not detected
Anti-Ri Not detected
Anti-Yo Not detected
Anti-CV2/CRMP5 Not detected
Anti-Ma2/Ta Not detected
Anti-Amphiphysin Not detected

What does this test Neuronal (Paraneoplastic) Autoantibodies Profile, CSF identify?

  • This test identifies autoantibodies that target neuronal antigens in the central nervous system.
  • It helps in diagnosing paraneoplastic neurological syndromes, which are a group of disorders that affect the nervous system and are associated with cancer.
  • These autoantibodies can be detected in the cerebrospinal fluid (CSF) of patients with neurological symptoms.
  • Identification of specific autoantibodies can provide valuable information for diagnosis, prognosis, and treatment of patients with paraneoplastic neurological syndromes.

Why is this test Neuronal (Paraneoplastic) Autoantibodies Profile, CSF taken?

Neuronal (Paraneoplastic) Autoantibodies Profile, CSF

Why is this test taken?

The Neuronal (Paraneoplastic) Autoantibodies Profile, CSF test is taken to detect the presence of autoantibodies in the cerebrospinal fluid (CSF) that are associated with paraneoplastic neurological syndromes. Paraneoplastic neurological syndromes are rare disorders that occur when the immune system mistakenly attacks normal cells in the nervous system in response to a tumor elsewhere in the body.

These autoantibodies can cause a variety of neurological symptoms, including muscle weakness, difficulty walking, sensory disturbances, and cognitive impairment. Detecting these autoantibodies can help diagnose and manage paraneoplastic neurological syndromes, as well as identify any underlying tumors that may be triggering the immune response.

The test is typically ordered when a healthcare provider suspects a paraneoplastic neurological syndrome based on a patient's symptoms, medical history, and other diagnostic tests. It can help confirm the diagnosis and guide treatment decisions.

No FAQs available.

Customer Google Rating